Application of DaTQUANT with Optimal Thresholding for Diagnostic Accuracy of Dopamine Transporter SPECT in Parkinsons Disease (PD) and Dementia with Lewy Body (DLB) Populations Read more about Application of DaTQUANT with Optimal Thresholding for Diagnostic Accuracy of Dopamine Transporter SPECT in Parkinsons Disease (PD) and Dementia with Lewy Body (DLB) Populations
Tucson Indian Center 2024 Cultural Assessment Read more about Tucson Indian Center 2024 Cultural Assessment
Expanding Localized Air Quality Monitoring at Pima County Schools to Address Environmental Justice Read more about Expanding Localized Air Quality Monitoring at Pima County Schools to Address Environmental Justice
Evaluation Services for the Health in Arizona Policy Initiative (HAPI) Program Read more about Evaluation Services for the Health in Arizona Policy Initiative (HAPI) Program
Project Title Inflammatory Bowel Disease (IBD) West Case Conference Read more about Project Title Inflammatory Bowel Disease (IBD) West Case Conference
Inflammatory Bowel Disease West Case Conference Read more about Inflammatory Bowel Disease West Case Conference
Study to Evaluate Safety, Efficacy and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients Read more about Study to Evaluate Safety, Efficacy and Tolerability of ABBV-950 for the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Read more about RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Protocol Title: A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS) Read more about Protocol Title: A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)
